PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1985 | 1 |
| 1993 | 2 |
| 1994 | 4 |
| 1995 | 3 |
| 1996 | 4 |
| 1997 | 1 |
| 1999 | 2 |
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 25 |
| 2007 | 55 |
| 2008 | 66 |
| 2009 | 57 |
| 2010 | 50 |
| 2011 | 53 |
| 2012 | 44 |
| 2013 | 55 |
| 2014 | 48 |
| 2015 | 45 |
| 2016 | 29 |
| 2017 | 25 |
| 2018 | 30 |
| 2019 | 20 |
| 2020 | 89 |
| 2021 | 49 |
| 2022 | 13 |
| 2023 | 14 |
| 2024 | 14 |
| 2025 | 12 |
| 2026 | 7 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Eur J Pharmacol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Cardiac hypertrophy at the crossroads: Mechanistic insights and emerging multimodal therapeutic strategies.
- Kannan D, Rajasingh S, Madasamy P, Rajasingh J.
- Eur J Pharmacol. Author manuscript. 2025 Sep 17;1006:178179. doi: 10.1016/j.ejphar.2025.178179.
- PMCID: PMC13639797
Kannan D, et al.Eur J Pharmacol. Author manuscript. 2025.PMCID: PMC13639797 -
Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice.
- Hye Khan MA, Goorani S, Atamanchuk A, Jankiewicz W, Yeboah MM, Barnett SD, Falck JR, Hwang SH, Barnych B, Hammock BD, El-Meanawy A, Imig JD.
- Eur J Pharmacol. Author manuscript. 2025 Sep 12;1006:178132. doi: 10.1016/j.ejphar.2025.178132.
- PMCID: PMC12632155
Hye Khan MA, et al.Eur J Pharmacol. Author manuscript. 2025.PMCID: PMC12632155 -
Overview of exosomal non-coding RNAs in cardiovascular disease using high throughput sequencing.
- Eivazi M, Abkhooie L, Hosseini K, Mobasheran P, Ebrahimi T, Tarhriz V, Lazartigues E.
- Eur J Pharmacol. Author manuscript. 2025 Oct 25;1007:178277. doi: 10.1016/j.ejphar.2025.178277.
- PMCID: PMC13521592
Eivazi M, et al.Eur J Pharmacol. Author manuscript. 2025.PMCID: PMC13521592 -
P-glycoprotein-mediated efflux of rapaprotin-L dictates sensitivity of cancer cells to the inducer of 26S proteasome disassembly.
- Zhang Q, Asbell T, Rao AVS, Pasunooti KK, Zhang J, Shi M, Domae AF, Rees MG, Roth JA, Mao Y, Liu JO.
- Eur J Pharmacol. Author manuscript. 2026 May 30;1030:179013. doi: 10.1016/j.ejphar.2026.179013.
- PMCID: PMC13394445
Zhang Q, et al.Eur J Pharmacol. Author manuscript. 2026.PMCID: PMC13394445 -
Inhibition of the serotonin transporter and risk of heart valve disease: A systematic review and meta-analysis.
- Campbell A, Adamo A, Bektik E, Kosuri Y, Karcher C, Levine D, Ramakrishnan R, Grau JB, Levy RJ, Ferrari G.
- Eur J Pharmacol. Author manuscript. 2026 May 9;1027:178954. doi: 10.1016/j.ejphar.2026.178954.
- PMCID: PMC13383871
Campbell A, et al.Eur J Pharmacol. Author manuscript. 2026.PMCID: PMC13383871 -
Repeated ethanol exposure in female rats impairs cerebral endothelial function and increases cerebrovascular stiffness.
- Baumoel EJ, Heitkamp MC, Thaqi A, Luchetta J, DeMarco GM, Karkhanis AN, Chapman AC.
- Eur J Pharmacol. Author manuscript. 2026 Jul 1;1030:179104. doi: 10.1016/j.ejphar.2026.179104.
- PMCID: PMC13373886
Baumoel EJ, et al.Eur J Pharmacol. Author manuscript. 2026.PMCID: PMC13373886 -
Reprogramming inflammation: Mechanisms and therapeutic targeting of eicosanoids and pro-resolving mediators.
- Kolawole OR, Kashfi K.
- Eur J Pharmacol. Author manuscript. 2025 Jul 5;1003:177924. doi: 10.1016/j.ejphar.2025.177924.
- PMCID: PMC12277037
Kolawole OR, et al.Eur J Pharmacol. Author manuscript. 2025.PMCID: PMC12277037 -
Mitochondrial dysfunction and senescence accompany glioblastoma cell death triggered by a putative metabolic inhibitor.
- Yadav A, Bhutkar S, Barot S, Aher AA, Patel K, Muth A, Dukhande V.
- Eur J Pharmacol. Author manuscript. 2026 Apr 24;1024:178893. doi: 10.1016/j.ejphar.2026.178893.
- PMCID: PMC13267918
Yadav A, et al.Eur J Pharmacol. Author manuscript. 2026.PMCID: PMC13267918 -
Combined effects of gabapentin with verapamil and metoprolol on cardiovascular function of anesthetized male rats.
- Pribil Pardun S, Duff S, Papenfus I, Bruening W, Li Y, Pendyala G, Gao L.
- Eur J Pharmacol. Author manuscript. 2025 Jun 6;1002:177828. doi: 10.1016/j.ejphar.2025.177828.
- PMCID: PMC13251811
Pribil Pardun S, et al.Eur J Pharmacol. Author manuscript. 2025.PMCID: PMC13251811 -
NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease.
- Firouzan B, Ghasemi R, Tetteh MT, Matson JB, Kashfi K.
- Eur J Pharmacol. Author manuscript. 2025 May 28;1002:177733. doi: 10.1016/j.ejphar.2025.177733.
- PMCID: PMC12229780
Firouzan B, et al.Eur J Pharmacol. Author manuscript. 2025.PMCID: PMC12229780